In the present study, we used less-strict criteria for investigating the importance of germline genetic variability in coding, untranslated regions (UTR), and adjacent regions of all human members of the CYP superfamily for prognosis and response to the neoadjuvant cytotoxic therapy (NACT) of breast cancer patients. The gene discussed is PPIG; the disease is breast cancer.